Literature DB >> 18348257

Revisiting metatropic dysplasia: presentation of a series of 19 novel patients and review of the literature.

D Geneviève1, M Le Merrer, J Feingold, A Munnich, P Maroteaux, V Cormier-Daire.   

Abstract

Metatropic dysplasia (MD-OMIM: 156530 and 250600) is a rare chondrodysplasia characterized by short limbs with limitation and enlargement of joints and usually severe kyphoscoliosis, first described in 1893. Up until now, 81 other patients have been reported. The phenotypic variability of MD has led to a classification based on radiological anomalies dividing into three different types: a lethal autosomal recessive form, an autosomal recessive non-lethal form and a non-lethal autosomal dominant form with less severe radiographs manifestations and a better clinical outcome. Here, we report on clinical and radiological features of 19 novel MD patients. We describe new radiological features, including precocious calcification of hyoid and cricoid cartilage, irregular and squared-off calcaneal bones and severe hypoplasia of the anterior portion of first cervical vertebrae. In addition, the observation of an overlap between the autosomal recessive non-lethal form and the non-lethal autosomal dominant form, the rarity of sibship recurrences and the observation of vertical transmissions of MD in the literature argue in favor of an autosomal dominant mode of inheritance for all MD types. This hypothesis is reinforced by the use of the statistical single ascertainment method that rejects the hypothesis of an autosomal recessive mode of inheritance responsible for MD. Therefore, we propose that recurrence in sibs is due to gonadal mosaicism. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18348257     DOI: 10.1002/ajmg.a.32191

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

1.  Prenatal diagnosis of metatropic dysplasia: beware of the pseudo-bowing sign.

Authors:  Catherine Garel; Amira Dhouib; Chiara Sileo; Valérie Cormier-Daire; Hubert Ducou le Pointe
Journal:  Pediatr Radiol       Date:  2014-03

Review 2.  The importance of conventional radiography in the mutational analysis of skeletal dysplasias (the TRPV4 mutational family).

Authors:  Stefan F Nemec; Daniel H Cohn; Deborah Krakow; Vincent A Funari; David L Rimoin; Ralph S Lachman
Journal:  Pediatr Radiol       Date:  2011-08-24

3.  Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia.

Authors:  Natalia Camacho; Deborah Krakow; Sharlin Johnykutty; Philip J Katzman; Samuel Pepkowitz; Joris Vriens; Bernd Nilius; Brendan F Boyce; Daniel H Cohn
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

4.  Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia.

Authors:  Deborah Krakow; Joris Vriens; Natalia Camacho; Phi Luong; Hannah Deixler; Tara L Funari; Carlos A Bacino; Mira B Irons; Ingrid A Holm; Laurie Sadler; Ericka B Okenfuss; Annelies Janssens; Thomas Voets; David L Rimoin; Ralph S Lachman; Bernd Nilius; Daniel H Cohn
Journal:  Am J Hum Genet       Date:  2009-02-19       Impact factor: 11.025

5.  A case of metatropic dysplasia: operative treatment of severe kyphoscoliosis and limb deformities.

Authors:  Hae Ryong Song; Shivam Sinha; Sang Heon Song; Seung Woo Suh
Journal:  Oman Med J       Date:  2013-11

6.  Increased basal activity is a key determinant in the severity of human skeletal dysplasia caused by TRPV4 mutations.

Authors:  Stephen Loukin; Zhenwei Su; Ching Kung
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

7.  Metatropic Dysplasia of Nonlethal Variant in a Chinese Child - A Case Report.

Authors:  Michele A Tchio Tchoumba; Yan Bai; Runming Jin; Xianying Yu; Musa Male
Journal:  Orthop Surg       Date:  2019-12-06       Impact factor: 2.071

Review 8.  The Induced Pluripotent Stem Cells in Articular Cartilage Regeneration and Disease Modelling: Are We Ready for Their Clinical Use?

Authors:  Michał S Lach; Monika A Rosochowicz; Magdalena Richter; Inga Jagiełło; Wiktoria M Suchorska; Tomasz Trzeciak
Journal:  Cells       Date:  2022-02-03       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.